EX-10.1 3 d783199dex101.htm EX-10.1 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under EXECUTION VERSION LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis LICENSE AND COLLABORATION AGREEMENT (the “Agreement”) is entered into as of August 11, 2014 (the “Execution Date”) between MANNKIND CORPORATION, a Delaware corporation, having a principal place of business at 28903 North Avenue Paine, Valencia, California 91355, USA (“MannKind”), TECHNOSPHERE INTERNATIONAL C.V., a Dutch limited partnership, having a principal place of business at 1097 JB Amsterdam, Prins Bernhardplein 200, Netherlands (“TICV”), MANNKIND NETHERLANDS B.V., a Dutch limited liability company, having a principal place of business at 1097 JB Amsterdam, Prins Bernhardplein 200, Netherlands (“BV” and together with MannKind and TICV, jointly and severally, the “Licensors”), and SANOFI-AVENTIS DEUTSCHLAND GMBH, a company organized and existing under the laws of Germany with a place of business at 65926 Frankfurt am Main, Germany (“Sanofi”).
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2014 Company Industry Jurisdiction* Expiration dates are computer generated and may not take into account patent term adjustments, patent term extensions, terminal disclaimers or the like. These dates should be used as general guides only.